If you have a biotechnology business model built on innovative drug candidates, devices or delivery technologies supported by powerful intellectual property and a grounded path to commercialization, we will invest.  We have an experienced team who believes that current environment in life sciences favors investors with both keen industry knowledge and specific opportunities in the pipeline.

We would welcome working closely with management in many areas, to build value in the companies' drug or technology development opportunities.  Most commonly, we deploy myriad development and regulatory expertise of our Principals and our contacts in the industry to garner the most value for our partners.